References
- Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Folding Disord 2003; 10: 160–184
- Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
- Shiomi K, Nakazato M, Matsukura S, Ohnishi A, Hatanaka H, Tsuji S, Murai Y, Kojima M, Kangawa K, Matsuo H. A basic transthyretin variant (Glu61 ––> Lys) causes familial amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced mutation restriction analysis. Biochem Biophys Res Commun 1993; 194: 1090–1096
- Yamamoto T, Matsunaga K, Ohnishi A, Nakazato M, Murai Y. A late onset familial amyloidotic polyneuropathy (FAP) with a novel variant transthyretin characterized by a basic-for-acidic amino acid substitution (Glu61 ––> Lys). Rinsho Shinkeigaku 1996; 36: 1065–1068
- Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y F, Masuda Y, Ikeda S. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest 1999; 6: 282–288
- Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999; 122: 1951–1962
- Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G. Study Group for Hereditary Neuropathy in Japan. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- versus late-onset form. Arch Neurol 2002; 59: 1771–1776
- Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N, Yokota T. Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 1987; 110: 315–337
- Ando Y, Suhr O B. Autonomic dysfunction in familial amyloid polyneuropathy (FAP). Amyloid: Int J Exp Clin Invest 1998; 5: 288–300
- Rapezzi C, Perugini E, Salvi F, Grigioni F, Riva L, Cooke R M, Ferlini A, Rimessi P, Bacchi-Reggiani L, Ciliberti P, Pastorelli F, Leone O, Bartolomei I, Pinna A D, Arpesella G, Branzi A. Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?. Amyloid: J Protein Folding Disord 2006; 13: 143–153
- Ikeda S. Cardiac amyloidosis: heterogeneous pathogenic background. Intern Med 2004; 43: 1107–1114